Paired comparisons indicated no statistically significant difference in serum GOLPH3 concentration at 1 week after surgery (median 6.19 ng/mL) and before surgery (median 6.38 ng/mL) in GC patients (P = 0.944). The gene discussed is GOLPH3; the disease is gastric cancer.